{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:08:36Z","timestamp":1792692516425,"version":"4.5.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM), a major driver of mortality worldwide, is more likely to develop other cardiometabolic risk factors, ultimately leading to diabetes-related mortality. Although a set of measures including lifestyle intervention and antidiabetic drugs have been proposed to manage T2DM, problems associated with potential side-effects and drug resistance are still unresolved. Pharmacomicrobiomics is an emerging field that investigates the interactions between the gut microbiome and drug response variability or drug toxicity. In recent years, increasing evidence supports that the gut microbiome, as the second genome, can serve as an attractive target for improving drug efficacy and safety by manipulating its composition. In this review, we outline the different composition of gut microbiome in T2DM and highlight how these microbiomes actually play a vital role in its development. Furthermore, we also investigate current state-of-the-art knowledge on pharmacomicrobiomics and microbiome\u2019s role in modulating the response to antidiabetic drugs, as well as provide innovative potential personalized treatments, including approaches for predicting response to treatment and for modulating the microbiome to improve drug efficacy or reduce drug toxicity.<\/jats:p>","DOI":"10.3389\/fendo.2023.1149256","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T05:20:09Z","timestamp":1679548809000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment"],"prefix":"10.3389","volume":"14","author":[{"given":"Liyang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc18-Sint01","article-title":"Introduction: Standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature."},{"key":"B3","volume-title":"IDF diabetes atlas","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S011","article-title":"11. microvascular complications and foot care: Standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11892-019-1244-0","article-title":"Personalized management of type 2 diabetes","volume":"19","author":"Peter","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034481","article-title":"Effectiveness of non-pharmacological strategies in the management of type 2 diabetes in primary care: a protocol for a systematic review and network meta-analysis","volume":"10","author":"Leite","year":"2020","journal-title":"BMJ Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.12.048","article-title":"Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction","volume":"152","author":"Bouter","year":"2017","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2016.0085","article-title":"Comparative fingerprinting of the human microbiota in diabetes and cardiovascular disease","volume":"19","author":"Vamanu","year":"2016","journal-title":"J Med Food"},{"key":"B9","doi-asserted-by":"publisher","first-page":"108689","DOI":"10.1016\/j.diabres.2021.108689","article-title":"Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: A systematic review","volume":"173","author":"Umirah","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1757-4749-4-16","article-title":"Gut pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes","volume":"4","author":"Saad","year":"2012","journal-title":"Gut Pathog"},{"key":"B16","doi-asserted-by":"publisher","first-page":"bbaa292","DOI":"10.1093\/bib\/bbaa292","article-title":"Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine","volume":"22","author":"Hassan","year":"2021","journal-title":"Brief Bioinform"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0874","article-title":"Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus","volume":"172","author":"Allin","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0264-8","article-title":"Synthetic ecology of the human gut microbiota","volume":"17","author":"Vrancken","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6323","article-title":"Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how","volume":"22","author":"Hou","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2018.10.003","article-title":"Gut microbiome and type 2 diabetes: where we are and where to go","volume":"63","author":"Sharma","year":"2019","journal-title":"J Nutr Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2017.08.038","article-title":"Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals","volume":"111","author":"Sedighi","year":"2017","journal-title":"Microb Pathog"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.722206","article-title":"Gut bacterial characteristics of patients with type 2 diabetes mellitus and the application potential","volume":"12","author":"Que","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/microorganisms8010094","article-title":"Characterization of the gut microbiota of individuals at different T2D stages reveals a complex relationship with the host","volume":"8","author":"Ch\u00e1vez-Carbajal","year":"2020","journal-title":"Microorganisms"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00214","article-title":"Gut microbial diversity assessment of Indian type-2-Diabetics reveals alterations in eubacteria, archaea, and eukaryotes","volume":"8","author":"Bhute","year":"2017","journal-title":"Front Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1238-8","article-title":"The integrative human microbiome project","volume":"569","year":"2019","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1038\/s41598-020-62224-3","article-title":"Implication of the gut microbiome composition of type 2 diabetic patients from northern China","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2018.11.019","article-title":"The alteration of gut microbiota in newly diagnosed type 2 diabetic patients","author":"Chen","year":"2019","journal-title":"Nutrition"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/microorganisms8091360","article-title":"Akkermansia muciniphila is negatively correlated with hemoglobin A1c in refractory diabetes","volume":"8","author":"Shih","year":"2020","journal-title":"Microorganisms."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-016-0271-6","article-title":"Sub-Clinical detection of gut microbial biomarkers of obesity and type 2 diabetes","volume":"8","author":"Yassour","year":"2016","journal-title":"Genome Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00295","article-title":"Integrative analysis toward different glucose tolerance-related gut microbiota and diet","volume":"10","author":"Nuli","year":"2019","journal-title":"Front Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02103-8","article-title":"Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications","volume":"66","author":"Zhao","year":"2019","journal-title":"Endocrine."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00578-19","article-title":"The gut microbial diversity of newly diagnosed diabetics but not of prediabetics is significantly different from that of healthy nondiabetics","volume":"5","author":"Gaike","year":"2020","journal-title":"mSystems"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1038\/s41598-019-41195-0","article-title":"Diabetic cats have decreased gut microbial diversity and a lack of butyrate producing bacteria","volume":"9","author":"Kieler","year":"2019","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41598-018-37242-x","article-title":"Microbiome alteration in type 2 diabetes mellitus model of zebrafish","volume":"9","author":"Okazaki","year":"2019","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S240728","article-title":"Phocea, pseudoflavonifractor and lactobacillus intestinalis: Three potential biomarkers of gut microbiota that affect progression and complications of obesity-induced type 2 diabetes mellitus","volume":"13","author":"Wang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00232","article-title":"Dynamic development of fecal microbiome during the progression of diabetes mellitus in zucker diabetic fatty rats","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102469","article-title":"Abnormal gut microbiota composition contributes to the development of type 2 diabetes mellitus in db\/db mice","volume":"11","author":"Yu","year":"2019","journal-title":"Aging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/nu11102310","article-title":"Loss of diurnal oscillatory rhythms in gut microbiota correlates with changes in circulating metabolites in type 2 diabetic db\/db mice","volume":"11","author":"Beli","year":"2019","journal-title":"Nutrients."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-020-02403-0","article-title":"Genistein ameliorates inflammation and insulin resistance through mediation of gut microbiota composition in type 2 diabetic mice","volume":"60","author":"Yang","year":"2021","journal-title":"Eur J Nutr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100536","article-title":"Decreased abundance of akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1039\/D1FO00882J","article-title":"Lactobacillus casei LC89 exerts antidiabetic effects through regulating hepatic glucagon response and gut microbiota in type 2 diabetic mice","volume":"12","author":"Zhang","year":"2021","journal-title":"Food Funct"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12986","article-title":"Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression","volume":"12","author":"Xu","year":"2020","journal-title":"J Diabetes."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/jpm12040617","article-title":"Interrelationship of gut microbiota, obesity, body composition and insulin resistance in asians with type 2 diabetes mellitus","volume":"12","author":"Pai","year":"2022","journal-title":"J Pers Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.14107","article-title":"Gut microbiome and its role in obesity and insulin resistance","volume":"1461","author":"Lee","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"159234","DOI":"10.1016\/j.bbalip.2022.159234","article-title":"Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota","volume":"1867","author":"Deng","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609134","article-title":"Berberine slows the progression of prediabetes to diabetes in zucker diabetic fatty rats by enhancing intestinal secretion of glucagon-like peptide-2 and improving the gut microbiota","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/jam.13276","article-title":"Effects of lactobacillus plantarum CCFM0236 on hyperglycaemia and insulin resistance in high-fat and streptozotocin-induced type 2 diabetic mice","volume":"121","author":"Li","year":"2016","journal-title":"J Appl Microbiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.03.022","article-title":"Antidiabetic effect of lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin","volume":"30","author":"Chen","year":"2014","journal-title":"Nutrition."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1039\/C7FO00593H","article-title":"Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism","volume":"8","author":"Wang","year":"2017","journal-title":"Food Funct"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3920\/BM2016.0090","article-title":"Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats","volume":"8","author":"Singh","year":"2017","journal-title":"Benef Microbes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","article-title":"Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-\u03baB, and up-regulating expression of MicroRNA-21","volume":"152","author":"Yang","year":"2017","journal-title":"Gastroenterology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","article-title":"A novel ruminococcus gnavus clade enriched in inflammatory bowel disease patients","volume":"9","author":"Hall","year":"2017","journal-title":"Genome Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.09.001","article-title":"Metformin and systemic metabolism","volume":"41","author":"He","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02392-17","article-title":"Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial","volume":"9","author":"Tong","year":"2018","journal-title":"mBio"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1093\/gerona\/glaa056","article-title":"Metformin reduces aging-related leaky gut and improves cognitive function by beneficially modulating gut Microbiome\/Goblet Cell\/Mucin axis","volume":"75","author":"Ahmadi","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/life10090195","article-title":"The effects of metformin on the gut microbiota of patients with type 2 diabetes: A two-center, quasi-experimental study","volume":"10","author":"Nakajima","year":"2020","journal-title":"Life"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.573891","article-title":"Effects of non-insulin anti-hyperglycemic agents on gut microbiota: A systematic review on human and animal studies","volume":"11","author":"Cao","year":"2020","journal-title":"Front Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"109131","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice","volume":"118","author":"Zhang","year":"2019","journal-title":"BioMed Pharmacother."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.640347","article-title":"Metformin affects gut microbiota composition and diversity associated with amelioration of dextran sulfate sodium-induced colitis in mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"110966","DOI":"10.1016\/j.biopha.2020.110966","article-title":"Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db\/db mice","volume":"133","author":"Madsen","year":"2021","journal-title":"BioMed Pharmacother."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02041-5","article-title":"Response of gut microbiota in type 2 diabetes to hypoglycemic agents","volume":"66","author":"Zhang","year":"2019","journal-title":"Endocrine."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s11101-021-09773-1","article-title":"A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes","volume":"21","author":"Dirir","year":"2022","journal-title":"Phytochem Rev"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/nu13062107","article-title":"Habitual dietary intake affects the altered pattern of gut microbiome by acarbose in patients with type 2 diabetes","volume":"13","author":"Takewaki","year":"2021","journal-title":"Nutrients"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12232","article-title":"Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus","volume":"7","author":"Su","year":"2015","journal-title":"J Diabetes."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000717","article-title":"Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in zucker diabetic fatty rats","volume":"7","author":"Zhang","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04091-0","article-title":"The human microbiome encodes resistance to the antidiabetic drug acarbose","volume":"600","author":"Balaich","year":"2021","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0147","article-title":"Role of intestinal microbiota in metabolism of voglibose In vitro and in vivo","volume":"44","author":"Nepal","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac210","article-title":"Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes","volume":"107","author":"Deng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.11.005","article-title":"Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes","volume":"46","author":"van Bommel","year":"2020","journal-title":"Diabetes Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-018-0708-x","article-title":"SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00635","article-title":"Dapagliflozin modulates the fecal microbiota in a type 2 diabetic rat model","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12933-021-01366-8","article-title":"GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1535370217743765","article-title":"Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats","volume":"243","author":"Zhang","year":"2018","journal-title":"Exp Biol Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11128","article-title":"Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus","volume":"9","author":"Shang","year":"2021","journal-title":"PeerJ."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.814770","article-title":"Gut microbial signatures for glycemic responses of GLP-1 receptor agonists in type 2 diabetic patients: A pilot study","volume":"12","author":"Tsai","year":"2021","journal-title":"Front Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01657-8","article-title":"Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion","volume":"58","author":"Charpentier","year":"2021","journal-title":"Acta Diabetol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.diabet.2021.101223","article-title":"Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes","volume":"47","author":"Smits","year":"2021","journal-title":"Diabetes Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/ph14060586","article-title":"Dipeptidyl peptidase (DPP)-IV inhibitors with antioxidant potential isolated from natural sources: A novel approach for the management of diabetes","volume":"14","author":"Singh","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.03.057","article-title":"Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis","volume":"44","author":"Liao","year":"2019","journal-title":"EBioMedicine."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4647-6","article-title":"The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice","volume":"61","author":"Olivares","year":"2018","journal-title":"Diabetologia."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184735","article-title":"Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats","volume":"12","author":"Zhang","year":"2017","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","article-title":"Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice","volume":"44","author":"Ryan","year":"2020","journal-title":"Can J Diabetes."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13760","article-title":"Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: A systematic review and meta-analysis","volume":"21","author":"Tian","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"153455","DOI":"10.1016\/j.phymed.2020.153455","article-title":"Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis","volume":"88","author":"Zheng","year":"2021","journal-title":"Phytomedicine."},{"key":"B100","doi-asserted-by":"publisher","first-page":"115997","DOI":"10.1016\/j.jep.2022.115997","article-title":"Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in kkay mice by reshaping gut microbiota and fecal metabolic profiles","volume":"303","author":"Zhou","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1051962","article-title":"Baihu renshen decoction ameliorates type 2 diabetes mellitus in rats through affecting gut microbiota enhancing gut permeability and inhibiting TLR4\/NF-\u03baB-mediated inflammatory response","volume":"12","author":"Yao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.1036380","article-title":"Buyang huanwu decoction affects gut microbiota and lipid metabolism in a ZDF rat model of co-morbid type 2 diabetes mellitus and obesity: An integrated metabolomics analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Front Chem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1029409","article-title":"Effects of danggui buxue decoction on host gut microbiota and metabolism in GK rats with type 2 diabetes","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3255401","DOI":"10.1155\/2022\/3255401","article-title":"Fufang fanshiliu decoction revealed the antidiabetic effect through modulating inflammatory response and gut microbiota composition","volume":"2022","author":"Li","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.900021","article-title":"Scrophulariae radix-atractylodes sinensis pair and metformin inhibit inflammation by modulating gut microbiota of high-fat diet\/streptozotocin-induced diabetes in rats","volume":"13","author":"Guo","year":"2022","journal-title":"Front Microbiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01922-y","article-title":"The potential mechanism of liu-Wei-Di-Huang pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism","volume":"59","author":"Yi","year":"2022","journal-title":"Acta Diabetol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"123189","DOI":"10.1016\/j.jchromb.2022.123189","article-title":"Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites","volume":"1194","author":"Zhang","year":"2022","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic effects of gegen qinlian decoction via the gut microbiota are attributable to its key ingredient berberine","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinf"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5585952","DOI":"10.1155\/2021\/5585952","article-title":"Ge-Gen-Jiao-Tai-Wan affects type 2 diabetic rats by regulating gut microbiota and primary bile acids","volume":"2021","author":"Chen","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PloS Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell."},{"key":"B114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.csbj.2021.12.006","article-title":"Modeling approaches for probing cross-feeding interactions in the human gut microbiome","volume":"20","author":"Saa","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00553-4","article-title":"Moving beyond descriptive studies: harnessing metabolomics to elucidate the molecular mechanisms underpinning host-microbiome phenotypes","volume":"15","author":"Bishop","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00784-021-04027-y","article-title":"Characterization of salivary microbiota in elderly patients with type 2 diabetes mellitus: a matched case-control study","volume":"26","author":"Omori","year":"2022","journal-title":"Clin Oral Investig"},{"key":"B117","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3892\/etm.2022.11234","article-title":"Application of machine learning tools: Potential and useful approach for the prediction of type 2 diabetes mellitus based on the gut microbiome profile","volume":"23","author":"Ge","year":"2022","journal-title":"Exp Ther Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","article-title":"How informative is the mouse for human gut microbiota research","volume":"8","author":"Nguyen","year":"2015","journal-title":"Dis Model Mech"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000481519","article-title":"Gut microbiota-dependent modulation of energy metabolism","volume":"10","author":"Heiss","year":"2018","journal-title":"J Innate Immun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12088-019-00825-x","article-title":"Interplay of human gut microbiome in health and wellness","volume":"60","author":"Singhvi","year":"2020","journal-title":"Indian J Microbiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"16203","DOI":"10.1038\/nmicrobiol.2016.203","article-title":"Culture of previously uncultured members of the human gut microbiota by culturomics","volume":"1","author":"Lagier","year":"2016","journal-title":"Nat Microbiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-018-0547-2","article-title":"Pharmacomicrobiomics: a novel route towards personalized medicine","volume":"9","author":"Doestzada","year":"2018","journal-title":"Protein Cell"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.853771","article-title":"Gut microbiota and antidiabetic drugs: Perspectives of personalized treatment in type 2 diabetes mellitus","volume":"12","author":"Liu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell."},{"key":"B127","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-micro-060221-012134","article-title":"Genome-scale metabolic modeling of the human microbiome in the era of personalized medicine","volume":"75","author":"Heinken","year":"2021","journal-title":"Annu Rev Microbiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"101507","DOI":"10.1016\/j.beem.2021.101507","article-title":"Gut microbiome, prebiotics, intestinal permeability and diabetes complications","volume":"35","author":"Snelson","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-020-02414-x","article-title":"Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in uox-knockout mice","volume":"60","author":"Guo","year":"2021","journal-title":"Eur J Nutr"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/nu12072041","article-title":"Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: A randomised controlled pilot study","volume":"12","author":"Palacios","year":"2020","journal-title":"Nutrients"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.05.005","article-title":"Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future","volume":"33","author":"Hanssen","year":"2021","journal-title":"Cell Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.820367","article-title":"Prospective study reveals host microbial determinants of clinical response to fecal microbiota transplant therapy in type 2 diabetes patients","volume":"12","author":"Ding","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1149256\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T05:20:12Z","timestamp":1679548812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1149256\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":132,"alternative-id":["10.3389\/fendo.2023.1149256"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1149256","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"article-number":"1149256"}}